The DOI matches its Crossref record; 184 of the 185 references it cites were found in a registry or an index.
Apoptosis and necroptosis in the liver: a matter of life and death
Open accessAbstract
Cell death represents a basic biological paradigm that governs outcomes and long-term sequelae in almost every hepatic disease condition. Acute liver failure is characterized by massive loss of parenchymal cells but is usually followed by restitution ad integrum. By contrast, cell death in chronic liver diseases often occurs at a lesser extent but leads to long-term alterations in organ architecture and function, contributing to chronic hepatocyte turnover, the recruitment of immune cells and activation of hepatic stellate cells. These chronic cell death responses contribute to the development of liver fibrosis, cirrhosis and cancer. It has become evident that, besides apoptosis, necroptosis is a highly relevant form of programmed cell death in the liver. Differential activation of specific forms of programmed cell death might not only affect outcomes in liver diseases but also offer novel opportunities for therapeutic intervention. Here, we summarize the underlying molecular mechanisms and open questions about disease-specific activation and roles of programmed cell death forms, their contribution to response signatures and their detection. We focus on the role of apoptosis and necroptosis in acute liver injury, nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH) and liver cancer, and possible translations into clinical applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A key feature of MASH is hepatocyte apoptosis, which correlates with the clinically most important feature of the disease, liver fibrosis (6, 7).”
From Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction–associated steatohepatitis (2025) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The current study amends this fibrocentric concept by demonstrating fibrosis-independent roles for HSCs through RSPO3, regulating critical parameters that affect CLD progression and outcomes, including metabolic hepatocyte functions, liver regeneration and hepatocyte death2,49,50.”
From Hepatic stellate cells control liver zonation, size and functions via R-spondin 3 (2025) · cites this paper as [50]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Hepatocyte apoptosis is a key feature of metabolic dysfunction–associated steatohepatitis (MASH)”
From Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction–associated steatohepatitis (2025) · cites this paper as [6]
In the citing paper
“In NASH, hepatocytes undergo apoptosis, necroptosis or pyroptosis (a newly described caspase 1-dependent apoptosis observed in NASH),33 thereby initiating inflammation in several ways.”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [33]
In the citing paper
“Whilst this process has anti-inflammatory potential, as it removes intracellular content which could otherwise act as DAMPs, efferocytosis also triggers macrophages to release transforming growth factor (TGF)β.”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [33]
In the citing paper
“This signalling pathway positively and negatively modulates inflammation in a number of ways, including via the activation of HSCs, a key source of scar-producing myofibroblasts.33,41”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Apoptosis and Molecular Targeting Therapy in Cancer
Hassan, M. K., Watari, H., Abu-Almaaty, A. H., Ohba, Y., & Sakuragi, N. (2014) · BioMed Research International · doi:10.1155/2014/150845 · Cited by 1,155
RetractedFerroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Stockwell, B. R., Friedmann Angeli, J. P., Bayir, H., Bush, A. I., Conrad, M., Dixon, S. J., Fulda, S., Gascón, S., Hatzios, S. K., Kagan, V. E., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.021 · Cited by 7,695
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,332
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
Friedmann Angeli, J. P., Schneider, M., Proneth, B., Tyurina, Y. Y., Tyurin, V. A., Hammond, V. J., Herbach, N., Aichler, M., Walch, A., Eggenhofer, E., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3064 · Cited by 3,732
Apoptosis, oncosis, and necrosis. An overview of cell death.
Majno, G., & Joris, I. (1995) · PubMed · Cited by 3,328
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327
Cited by
Sorted by citations
Items 101–200 of 589
Yu, X.-D., & Wang, J. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115157 · Cited by 54
Spatial genomics: mapping human steatotic liver disease
Matchett, K. P., Paris, J., Teichmann, S. A., & Henderson, N. C. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00915-2 · Cited by 53
Marquardt, J. U., & Edlich, F. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01421 · Cited by 51
Necroptosis Underlies Hepatic Damage in a Piglet Model of Lipopolysaccharide-Induced Sepsis
Xu, Q., Guo, J., Li, X., Wang, Y., Wang, D., Xiao, K., Zhu, H., Wang, X., Hu, C. A., Zhang, G., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.633830 · Cited by 50
Ishtiaq, S. M., Arshad, M. I., & Khan, J. A. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108298 · Cited by 48
Iron Metabolism and Ferroptosis in Peripheral Nerve Injury
Huang, L., Bian, M., Zhang, J., & Jiang, L. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/5918218 · Cited by 51
The role and mechanisms of macrophage polarization and hepatocyte pyroptosis in acute liver failure
Xie, D., & Ouyang, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1279264 · Cited by 49
Shi, S., Verstegen, M. M. A., Mezzanotte, L., de Jonge, J., Löwik, C. W. G. M., & van der Laan, L. J. W. (2019) · Liver Transplantation · doi:10.1002/lt.25488 · Cited by 48
Have incidence rates of liver cancer peaked in the United States?
Petrick, J. L., Florio, A. A., Loomba, R. S., & McGlynn, K. A. (2020) · Cancer · doi:10.1002/cncr.32794 · Cited by 48
Antifibrotic therapies for metabolic dysfunction-associated steatotic liver disease
Schwabe, R. F., Tacke, F., Sugimoto, A., & Friedman, S. L. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101421 · Cited by 52
Self-citationKo, I., Jin, J., Hwang, L., Kim, S., Kim, C., Han, J., Lee, S., Kim, H. I., Shin, H. P., & Jeon, J. W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217894 · Cited by 46
Samy, A. M., Kandeil, M. A., Sabry, D., Abdel-Ghany, A. A., & Mahmoud, M. O. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30387 · Cited by 55
The Role of Necroptosis: Biological Relevance and Its Involvement in Cancer
Torre, L. D., Nebbioso, A., Stunnenberg, H. G., Martens, J. H. A., Carafa, V., & Altucci, L. (2021) · Cancers · doi:10.3390/cancers13040684 · Cited by 46
Zhao, L., Liang, J., Liu, H., Gong, C., Huang, X., Hu, Y., Liu, Q., He, Z., Zhang, X., Yang, S. Y., et al. (2022) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2022.05.015 · Cited by 45
Liu, S., Yang, Y., Hussain, N., Jian, Y., Li, B., Qiu, Y., Yu, H., Wang, H.-Z., & Wang, W. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106872 · Cited by 46
Mohammed, O. S., Attia, H. G., Mohamed, B. M. S. A., Elbaset, M. A., & Fayed, H. M. (2023) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.3389/jpps.2023.11808 · Cited by 48
Yang, Y., Fan, S., Chen, Q., Lu, Y., Zhu, Y., Chen, X., Xia, L., Huang, Q., Zheng, J., & Liu, X. Z. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01203-w · Cited by 46
Koschel, J., Nishanth, G., Just, S., Harit, K., Kröger, A., Deckert, M., Naumann, M., & Schlüter, D. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00752-9 · Cited by 43
Miyata, T., Wu, X., Fan, X., Huang, E., Sanz‐García, C., Ross, C. K. C., Roychowdhury, S., Bellar, A., McMullen, M. R., Dasarathy, J., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.140180 · Cited by 45
Scavenging ROS to Alleviate Acute Liver Injury by ZnO‐NiO@COOH
Wu, X., Liu, S., Zhu, H., Ma, Z., Dai, X., & Liu, W. (2022) · Advanced Science · doi:10.1002/advs.202103982 · Cited by 44
Yuan, Y., Li, Y., Li, L., Liu, H., Pang, Y., & Yan, H. (2022) · Toxicology Letters · doi:10.1016/j.toxlet.2022.08.007 · Cited by 39
Intestine-liver crosstalk in Type 2 Diabetes and non-alcoholic fatty liver disease
Nawrot, M., Peschard, S., Lestavel, S., & Staels, B. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154844 · Cited by 49
Yan, Z., Jiao, H., Chen, J., Zhang, K., Wang, X., Jiang, Y.-M., Liu, Y., Xue, Z., Ma, Q., Li, X., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.773562 · Cited by 43
Xue, Y., Jiang, X., Wang, J., Zong, Y., Yuan, Z., Miao, S., & Mao, X. (2023) · Biomarker Research · doi:10.1186/s40364-022-00433-w · Cited by 43
Zhu, M., Liu, D., Liu, G., Zhang, M., & Pan, F. (2023) · Biomolecules · doi:10.3390/biom13121715 · Cited by 42
Yuan, Z., Yuan, Z., Hasnat, M., Zhang, H., Liang, P., Sun, L., Jiang, Z., & Zhang, L. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.02.009 · Cited by 42
The dichotomous role of TGF-β in controlling liver cancer cell survival and proliferation
Zhang, K., Zhang, M., Luo, Z., Wen, Z., & Yan, X. (2020) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2020.09.005 · Cited by 45
Zhou, H., Liu, Y., Su, Y., Ji, P., Kong, L., Sun, R., Zhang, D., Xu, H., Li, W., & Li, W. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117794 · Cited by 45
Zhang, J., Yang, F., Mei, X., Yang, R., Lu, B., Wang, Z., & Ji, L. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109739 · Cited by 41
Sun, L., Chen, Y., Luo, H., Xu, M., Meng, G., & Zhang, W. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.02.022 · Cited by 38
Ghallab, A., Myllys, M., Friebel, A., Duda, J., Edlund, K., Halilbasic, E., Vucur, M., Hobloss, Z., Brackhagen, L., Begher‐Tibbe, B., et al. (2021) · Cells · doi:10.3390/cells10102516 · Cited by 42
Self-citationLu, Z., Wu, C.-P., Zhu, M., Song, W., Wang, H., Wang, J., Guo, J., Li, N., Liu, J., Li, Y., et al. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4945 · Cited by 39
The pathogenesis of organ fibrosis: Focus on necroptosis
Hao, M., Han, X., Yao, Z., Zhang, H., Zhao, M., Peng, M., Wang, K., Shan, Q., Sang, X., Wu, X., et al. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15952 · Cited by 40
Shen, Y., Chang, N., Li, W., Yang, T., Xue, R., Liu, J., Zhang, L., Yao, X., Chen, Y., Wang, H., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05615-4 · Cited by 38
Mechanisms of nonalcoholic fatty liver disease and implications for surgery
Kaufmann, B. K., Reca, A., Wang, B., Friess, H., Feldstein, A. E., & Hartmann, D. (2020) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-020-01965-1 · Cited by 39
Liver Fibrosis—From Mechanisms of Injury to Modulation of Disease
Liedtke, C., Nevzorova, Y. A., Luedde, T., Zimmermann, H. W., Kroy, D. C., Strnad, P., Berres, M., Bernhagen, J., Tacke, F., Nattermann, J., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.814496 · Cited by 43
Self-citationFDX1 inhibits thyroid cancer malignant progression by inducing cuprotosis
Chen, G., Zhang, J., Teng, W., Luo, Y., & Ji, X. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18655 · Cited by 37
Assis, M. B. D. S., de Moraes, G., & de Souza, K. R. (2024) · Biomedical Reports · doi:10.3892/br.2024.1736 · Cited by 37
Immunological mechanisms in steatotic liver diseases: An overview and clinical perspectives
Yan, M., Man, S., Ma, L., Guo, L., Huang, L., & Gao, W. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0315 · Cited by 39
Mechanism of Bile Acid-Induced Programmed Cell Death and Drug Discovery against Cancer: A Review
Jang, J. Y., Im, E., Choi, Y. H., & Kim, N. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137184 · Cited by 36
Betulinic acid in the treatment of breast cancer: Application and mechanism progress
Mu, H., Sun, Y., Yuan, B., & Wang, Y. (2023) · Fitoterapia · doi:10.1016/j.fitote.2023.105617 · Cited by 36
Yadav, P., Singh, S. K., Rajput, S., Allawadhi, P., Khurana, A., Weiskirchen, R., & Navik, U. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108563 · Cited by 39
Current Therapeutic Landscape for Metabolic Dysfunction-Associated Steatohepatitis
Devasia, A. G., Ramasamy, A., & Leo, C. H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041778 · Cited by 45
Chronic Ethanol Consumption Induces Osteopenia via Activation of Osteoblast Necroptosis
Guo, M., Huang, Y., Wu, Q., Chai, L., Jiang, Z., Zeng, Y., Wan, S., Tan, X., Long, Y., Gu, J., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/3027954 · Cited by 39
Wu, J., Zhang, C., He, T., Zhang, S., Wang, Y., Xie, Z., Xu, W., Ding, C., Shuai, Y., Hao, H., et al. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175618 · Cited by 35
Krishna-Subramanian, S., Singer, S., Armaka, M., Bañales, J. M., Hölzer, K., Schirmacher, P., Walczak, H., Kollias, G. A., Pasparakis, M., & Kondylis, V. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0330-9 · Cited by 35
A Glimpse of necroptosis and diseases
Yang, M., Chen, W., He, L., Liu, D., Zhao, L., & Wang, X. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113925 · Cited by 38
Huang, L., Lu, S., Bian, M., Wang, J., Yu, J., Ge, J., Zhang, J., & Xu, Q. (2023) · Experimental Cell Research · doi:10.1016/j.yexcr.2023.113717 · Cited by 34
Research progress on AMPK in the pathogenesis and treatment of MASLD
Feng, J., Li, M., TingTing, Y., Yi, X., & HaiNing, G. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1558041 · Cited by 36
Tian, R.-D., Chen, Y., He, Y.-H., Tang, Y.-J., Chen, G.-M., Yang, F., Li, Y., Huang, W., Chen, H., Liu, X., et al. (2019) · Annals of Hepatology · doi:10.1016/j.aohep.2019.05.008 · Cited by 33
Cell-in-Cell Structures in the Liver: A Tale of Four E’s
Davies, S. P., Terry, L. V., Wilkinson, A. L., & Stamataki, Z. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00650 · Cited by 33
Zhirong, Z., Qiaojian, Z., Chunjing, X., Shengchen, W., Li, J., Liu, Z., & Li, S. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30145 · Cited by 33
A potent protective effect of baicalein on liver injury by regulating mitochondria-related apoptosis
Yu, Z., Li, Q., Wang, Y., & Li, P. (2020) · APOPTOSIS · doi:10.1007/s10495-020-01608-2 · Cited by 32
Li, M., Zhao, H., Wu, J., Wang, L., Wang, J., Lv, K., Liu, S., Wang, M., Guan, W., Liu, J., et al. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c01722 · Cited by 32
Altered mitochondrial calcium handling and cell death by necroptosis: An emerging paradigm
Faizan, M. I., & Ahmad, T. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.12.004 · Cited by 31
A narrative review of the role of necroptosis in liver disease: a double-edged sword
Li, X., Dong, G., Xiong, H., & Diao, H. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-5162 · Cited by 31
Koschel, J., Nishanth, G., Just, S., Harit, K., Kröger, A., Deckert, M., Naumann, M., & Schlüter, D. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00819-7 · Cited by 32
Chemopreventive role of arabinoxylan rice bran, MGN-3/Biobran, on liver carcinogenesis in rats
El-Din, N. K. B., Ali, D. A., Othman, R., French, S. W., & Ghoneum, M. H. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110064 · Cited by 31
Cantharidin‐induced acute hepatotoxicity: the role of TNF‐α, IKK‐α, Bcl‐2, Bax and caspase3
Yu, Y., Zhang, Y., Zhang, J., Guan, C., Liu, L., & Ren, L. (2020) · Journal of Applied Toxicology · doi:10.1002/jat.4003 · Cited by 31
Fibrinogen-like protein 2 in inflammatory diseases: A future therapeutic target
Li, F., Liu, Z., & Yang, L. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109799 · Cited by 31
UDP-glucuronate metabolism controls RIPK1-driven liver damage in nonalcoholic steatohepatitis
Zhang, T., Zhang, N., Xing, J., Zhang, S., Chen, Y., Xu, D., & Gu, J. (2023) · Nature Communications · doi:10.1038/s41467-023-38371-2 · Cited by 30
Efferocytosis in liver disease
Shi, H., Moore, M. P., Wang, X., & Tabas, I. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2023.100960 · Cited by 30
Xian, S., Yang, Y., Nan, N., Fu, X., Shi, J., Wu, Q., & Zhou, S. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118253 · Cited by 30
Necroptosis in Cholangiocarcinoma
Sarcognato, S., de Jong, I. E. M., Fabris, L., Cadamuro, M., & Guido, M. (2020) · Cells · doi:10.3390/cells9040982 · Cited by 30
The diverse roles of macrophages in metabolic inflammation and its resolution
Ray, A. G., Odum, O., Wiseman, D., & Weinstock, A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1147434 · Cited by 31
Xu, Q., Xu, J., Zhang, K., Zhong, M., Cao, H., Wei, R., Jin, L., & Gao, Y. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111159 · Cited by 32
Erfan, O. S., Sonpol, H. M. A., & El‐kader, M. A. (2021) · The Anatomical Record · doi:10.1002/ar.24587 · Cited by 28
Fungal-Induced Programmed Cell Death
Williams, T. J., Gonzales-Huerta, L. E., & Armstrong-James, D. P. H. (2021) · Journal of Fungi · doi:10.3390/jof7030231 · Cited by 30
Chen, Q., Wang, Y., Jiao, F., Cao, P., Shi, C., Pei, M., Wang, L., & Gong, Z. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16751 · Cited by 28
Liu, M., He, J. H., Zheng, S., Zhang, K., Ouyang, Y., Zhang, Y., Li, C., & Wu, D. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-2885 · Cited by 29
Negm, W. A., El-Kadem, A. H., Hussein, I. A., & Alqahtani, M. J. (2022) · Biomedicines · doi:10.3390/biomedicines10051134 · Cited by 29
Tang, S., Zhang, X., Duan, Z., Xu, M., Kong, M., Zheng, S., Bai, L., & Chen, Y. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109808 · Cited by 30
Shi, H., Wang, X., Sloas, C., Gerlach, B., Yurdagul, A., Moore, M. P., Jung, E. J., Mirshahi, F., Ronzoni, L., Sanyal, A. J., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adv2106 · Cited by 30
Mechanisms of liver fibrosis in metabolic syndrome
Mehal, W. (2023) · eGastroenterology · doi:10.1136/egastro-2023-100015 · Cited by 28
Lv, X., Zhou, H., Hu, K., Lin, L., Yang, Y., Li, L., Tang, L. P., Huang, J., Shen, Y., Jiang, R., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105838 · Cited by 28
Examination of the role of necroptotic damage-associated molecular patterns in tissue fibrosis
Liu, X., Lu, F., & Chen, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.886374 · Cited by 30
Wang, L., Liu, H., Zhou, L., Zheng, P., Li, H., Zhang, H., & Liu, W. (2024) · Nature and Science of Sleep · doi:10.2147/nss.s468420 · Cited by 28
Environmental exposure as a risk-modifying factor in liver diseases: Knowns and unknowns
Beier, J. I., & Arteel, G. E. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.09.005 · Cited by 29
Du, T., Fang, Q., Zhang, Z., Zhu, C., Xu, R., Chen, G., & Wang, Y. (2022) · Metabolites · doi:10.3390/metabo12010055 · Cited by 28
Chen, J., Wang, H., Zhou, L., Liu, Z., Chen, H., & Tan, X. (2022) · Cancer Medicine · doi:10.1002/cam4.4812 · Cited by 28
A novel NEDD4L-TXNIP-CHOP axis in the pathogenesis of nonalcoholic steatohepatitis
Guo, Q., Xin, M., Lu, Q., Feng, D., Yang, V., Peng, L. F., Whelan, K. A., Hu, W., Wu, S. L., Yang, X., et al. (2023) · Theranostics · doi:10.7150/thno.81192 · Cited by 28
Wang, Y., Ma, X., Zhou, C., Jia, Y., Liu, S., Xiong, Z., Guo, X., Fei, X., Jiang, X., & Yu, W. (2021) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2021.1946229 · Cited by 27
Hu, J., Ying, H., Zheng, Y., Ma, H., Li, L., & Zhao, Y. (2022) · Antioxidants · doi:10.3390/antiox11061070 · Cited by 27
Fibrogenic Pathways in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD)
Subramanian, P., Hampe, J., Tacke, F., & Chavakis, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23136996 · Cited by 35
State-of-the-art advancements in Liver-on-a-chip (LOC): Integrated biosensors for LOC
Liu, M., Xiang, Y., Yang, Y., Long, X., Xiao, Z., Nan, Y., Jiang, Y., Qiu, Y., Huang, Q., & Ai, K. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114758 · Cited by 28
Adverse effects and underlying mechanism of amorphous silica nanoparticles in liver
Liang, Q., Sun, M., Ma, Y., Wang, F., Sun, Z., & Duan, J. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.136955 · Cited by 27
Current, emerging, and potential therapies for non-alcoholic steatohepatitis
Yang, Z. L., & Wang, L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1152042 · Cited by 26
Jia, M., Li, Y.-Q., Xu, K., Zhang, Y., Tan, S., Zhang, Q., Peng, J., & Luo, X. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173041 · Cited by 28
Filliol, A. A., & Schwabe, R. F. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.01.002 · Cited by 27
Self-citationYu, Q., & Song, L. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1431652 · Cited by 27
XDeathDB: a visualization platform for cell death molecular interactions
Gadepalli, V. S., Kim, H., Liu, Y., Han, T., & Cheng, L. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04397-x · Cited by 29
Role of Necroptosis in Intervertebral Disc Degeneration
Khaleque, A., Kim, J. H., Hwang, B.-J., Kang, J.-K., Quan, M., & Kim, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015292 · Cited by 27
Tang, L., Wang, F., Xiao, L., Shen, M., Xia, S., Zhang, Z., Zhang, F., Zheng, S., & Tan, S. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114411 · Cited by 26
Zheng, Z., Zhao, Y., Yu, H., Wang, T., Li, J., Xu, L., Ding, C., He, L. Q., Wu, L., & Dong, Z. (2024) · Communications Biology · doi:10.1038/s42003-023-05664-7 · Cited by 25
Tian, X., Cheng, J., Yang, L., Li, Z., & Yu, M. (2024) · Chemical & Biomedical Imaging · doi:10.1021/cbmi.3c00123 · Cited by 25
Cell Death in Liver Disease and Liver Surgery
Stoess, C., Choi, Y., Onyuru, J., Friess, H., Hoffman, H. M., Hartmann, D., & Feldstein, A. E. (2024) · Biomedicines · doi:10.3390/biomedicines12030559 · Cited by 26
Meng, L., Ouyang, Z., Chen, Y., Huang, C., Yu, Y., & Fan, R. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.172655 · Cited by 26
At the Crossroads of Health and Disease: Consequences of Fat in the Liver
Dukewich, M., Yuan, L., & Terrault, N. A. (2025) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022724-105515 · Cited by 35
Kim, S., Kim, Y. K., Kim, S., Choi, Y., Lee, I., Joo, H., Kim, J., Kwon, M., Park, S., Jo, M. K., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57133-w · Cited by 25
Intracellular XBP1-IL-24 axis dismantles cytotoxic unfolded protein response in the liver
Wang, J., Hu, B., Zhao, Z., Zhang, H., Zhang, H., Zhao, Z., Ma, X., Shen, B., Sun, B., Huang, X., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-019-2209-6 · Cited by 25
Metadata
- Authors
- Schwabe, R. F., & Luedde, T.
- Affiliations
- Columbia University Irving Medical Center (US)
- Universitätsklinikum Aachen (DE)
- Corresponding author
- Schwabe, Robert F.
- Luedde, Tom
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2018-09-24
- Volume
- 15
- Issue
- 12
- Pages
- 738-752
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- PMC
- PMC6490680
- OpenAlex
- W2890337997
- Cited by
- 582
- References
- 185
- Citations by year
- 2026: 51 · 2025: 82 · 2024: 93 · 2023: 91 · 2022: 94 · 2021: 78 · 2020: 59 · 2019: 33
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (U01AA021912)
- National Cancer Institute (R01CA190844, R01CA200597)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK116620)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- apoptosis, necroptosis, programmed cell death, liver injury, acute liver failure, chronic liver disease, liver fibrosis, liver cirrhosis, liver cancer, non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, hepatic stellate cells, hepatocyte turnover, cell death detection
- MeSH terms
- Animals, Humans, Liver, Liver Diseases, Necrosis, Cell Death, Apoptosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
